- Open Access
Correction to: Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase
Cancer Cell International volume 21, Article number: 138 (2021)
Correction to: Cancer Cell Int (2019) 19:348 https://doi.org/10.1186/s12935-019-1069-6
Following publication of the original article , we were notified that the control group in the left panel of Figure 1c was incorrect, the labelling of the control group in Figure 1e was inconsistent.
Corrected Fig. 1 can be found below:
Also, the legend for Figure 2f needs to read: “Levels of expression of apoptosis related proteins BCL2 and BAX in S18 cells with a gradient of casticin concentrations (0, 1, 2, 4 µM), and C666-1 with a gradient of casticn concentrations (0, 2, 4 or 8 µM) analyzed by Western blotting.”
These changes don’t affect any of the conclusions. The authors apologise for any inconvenience.
Liu J, Yang J, Hou Y, Zhu Z, He J, Zhao H, Ye X, Li D, Wu Z, Huang Z, Hao B, Yao K. Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase. Cancer Cell Int. 2019;19:348. https://doi.org/10.1186/s12935-019-1069-6.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Liu, J., Yang, J., Hou, Y. et al. Correction to: Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase. Cancer Cell Int 21, 138 (2021). https://doi.org/10.1186/s12935-021-01844-9